Fenwick & West has represented Livermore, California-based computer-chip testing equipment maker FormFactor, Inc. (Nasdaq:FORM) in its initial public offering. The offering raised over $84 million for FormFactor, which issued 6,000,000 shares of common stock in the offering. The Fenwick & West team representing FormFactor was led by corporate partner Mark Leahy. The offering was underwritten […]

Baker & McKenzie announced today that it has significantly enhanced the depth of services provided by its Global Transfer Pricing Practice Group, a subgroup of the Firm’s Global Tax Practice. With the addition of Holly E. Glenn as a senior economist, Baker & McKenzie will enhance its ability to provide comprehensive economic and valuation services

Baker & McKenzie announced today that it acted for the Mathys family to reach agreement to combine Mathys Medizinaltechnik AG and Synthes-Stratec Inc. to create a global osteosynthesis medical device company. To effect the transaction, Synthes-Stratec is purchasing all Mathys shares for CHF 1 billion in cash and CHF 500 million in Synthes-Stratec equity, issuing

It’s homecoming time for two attorneys who will soon become the newest members of the Market Trial Practice Group in the Wilmington office of Reed Smith, a top -20 international law firm. Judith M. Kinney will join the firm on August 4, and John G. “Jack” Harris will rejoin the firm on July 8. Greg

Internationally prominent attorney Ko-Yung Tung has rejoined the law firm of O’Melveny & Myers LLP after serving as the Vice President and General Counsel at the World Bank and as Secretary General of the International Center for Settlement of Investment Disputes (ICSID). At the World Bank, Mr. Tung was responsible for all legal aspects of

Baker & McKenzie announced today that it advised Ceskoslovenska obchodni banka, a.s. (CSOB) on the transfer to the Czech Consolidation Agency (CKA) of shares in foreign fund structures established by the former Investicni a Postovni banka, a.s. (IPB) for a purchase price exceeding €1.6 billion. CSOB acquired the assets and liabilities of IPB in June

Aside from the Holocaust litigation that took place in the 1990s and some of which still continues;one thing still rings true in the simplest of terms; there were policies purchased, there were deaths, and there should have been payments. Only until recently have insurers begun to acknowledge the existence of policies, and still they continue

Linklaters has acted for Southern Water Services Limited (SWS) and its majority shareholder, Royal Bank Investments Limited (RBIL), the private equity arm of The Royal Bank of Scotland group, on its £1.9 billion whole business securitisation. The securitisation was co-arranged by The Royal Bank of Scotland (RBS) and Citigroup. To date, Linklaters has acted in

An intellectual property litigation legal team from McDermott, Will & Emery successfully represented The Burnham Institute and Integra LifeSciences, obtaining a significant victory related to patent infringement in the context of biomedical research. On June 6, 2003, the U.S. Court of Appeals for the Federal Circuit upheld a holding that Merck KGaA directly infringed and

Debevoise & Plimpton represented Benfield Group Limited as U.S. counsel on its initial public offering. Benfield’s IPO, raising total proceeds of £157 million, was the largest on the London Stock Exchange this year, and the only offering on its main market. The shares were distributed in the United States to institutional investors in a Rule